Castle Biosciences, Inc. · NASDAQ:CSTL

Oelschlager Kristen M sold 8,586 Castle Biosciences, Inc. shares (Form 4)

Traded Aug 3, 2026 · Filed Aug 5, 2026

On Aug 3, 2026, Oelschlager Kristen M (Chief Operating Officer) sold 8,586 Castle Biosciences, Inc. shares at an average US$29.77 for US$256K under a trading plan, leaving 13,288 shares. Filed Aug 5, 2026 (Form 4).

Sold
8,586 shares
Price
US$29.77 average (US$29.12 to US$30.62)
Value
US$256K
Holding after
13,288 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 3, 2026Common StockSale3,000US$29.1218,874Direct
Aug 3, 2026Common StockSale4,486US$30.0014,388Direct
Aug 3, 2026Common StockSale1,100US$30.6213,288Direct

Source

View original at SEC

Related